ISSN:

Journal Home

Experimental Hematology and Oncology Q1 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Experimental Hematology and Oncology is a journal indexed in SJR in Hematology and Oncology with an H index of 47. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1644,5 €. The scope of the journal is focused on haematology, oncology. It has an SJR impact factor of 3,092 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,092.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Hematology (Q1) Oncology (Q1)

Price

1644,5 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,092

SJR Impact factor

47

H Index

122

Total Docs (Last Year)

266

Total Docs (3 years)

11300

Total Refs

2136

Total Cites (3 years)

172

Citable Docs (3 years)

8.39

Cites/Doc (2 years)

92.62

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1
American Journal of Hematology Q1

Compare this journals

Aims and Scope

Haematology Oncology